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Effect of jejunal infusion of bile acids on small bowel
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SUMMARY The effect of jejunal infusion of glycochenodeoxycholic acid and glycocholic acid on
small bowel transit time, fastingjejunal motility and serum bile acid concentrations was investigated
in groups of five to six healthy subjects. Glycochenodeoxycholic acid at a concentration of 15 mmol/l
(total amount: 5 mmol) and glycocholic acid 15 mmol/I (total amount: 5 mmol), both with lecithin 2-5
mmol/l, delayed (p<002) small bowel transit when compared with a bile acid free infusion [158-3
(12-5) min v 111 7 (17-6) min and 103-3 (21 8) min v 70-0 (14-9) min], inhibited (p<0 01 and p<005
respectively) the percentage duration of pressure activity of phase 2 [13* 1 (1 -8)% v 28- 1 (3 4)% and
29-2 (5'5)% v 34-9 (3-9)%], but did not change duration of migrating motor complex, or of its
phases. Glycochenodeoxycholic acid 10 mmol/l (total amount: 3-3 mmol), either with or without
lecithin, did not delay small bowel transit significantly [145-0 (13-2) min v 115 0 (19-5) and 90-0
(11-7) min v 84 0 (8 3)]. When bile acids were infused, serum bile acid curves were similar to those
obtained after a liquid meal and the peak serum bile acid concentration occurred 33-7 (6 6) min
before (p<0001) completion of small bowel transit. These observations suggest a role for
endogenous bile acids in the regulation of small gut motility.
Bile acids and bile have been claimed to have
stimulatory effects on small intestinal motility and
transit, but data are discordant'` and no observations
are available in man. Dihydroxy bile acids have been
shown to inhibit water and electrolyte absorption in
the human jejunum6 and ileum7 and oral intake of
chenodeoxycholic acid for dissolution of gall stones
gives rise to diarrhoea in a considerable number of
patients.2' The effect is thought to be because of a
direct secretory action of the dihydroxy bile acid on
colonic mucosa"' but an increased ileal flow and rapid
small intestinal transit may be contributory factors. "
The present study was designed to clarify whether
bile acids affect small bowel motility and transit. Bile
acids were administered in physiological amounts
and in most experiments lecithin was added to the
infused solutions to mimic endogenous input of bile
acids which occurs in the physicochemical state of
mixed micelles.
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Methods
SUBJECTS
Eighteen healthy subjects (aged 19-32 years, 15
men) entered the study which was approved by the
Brent Health District Ethical Committee. Women
were studied in the follicular phase of the menstrual
cycle.
EXPERIMENTAL DESIGN
Each subject underwent measurement of the small
bowel transit time (SBT1) of lactulose during jejunal
infusion of saline alone and during infusion of at least
one of four solutions containing either glycocheno-
deoxycholic acid (GCDC) or glycocholic acid (GC)
in amounts comparable with an average bile acid
pool,'2'3 as described in Table 1. Throughout this
study the concentration of the bile acids infused is
expressed in mmol/l and the total amount admin-
istered in mmol. Fourteen subjects were infused with
one bile acid solution only, four were infused with
two bile acid solutions: one with GCDC 10 mmol/l
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Table 1 Solutionis used during all exrperiments.
Concentrations ofinfusates are expressed in mnnolll, with
total amounts in brackets
- Saline (n= 18)
- Saline+GCDC* 10 mmol/l (3-3 mmol) (n=5)
- Saline+GCDC 10 mmol/l (3-3 mmol)+lecithint 2-5 mmol/I (n= 5)
- Saline+GCDC 15 mmol/l (5 mmol)+lecithin 2 5 mmol/I (n=6)
- Saline+GCt 15 mmol/l (5 mmol)+Iccithin 2 5 mmol/l (n=6)
*Glycochenodeoxycholic aicid, as sodium salt. Sigma Chemical
Company Ltd, 98%X pure; tBDHI Chemicals Ltd, 90%, pure (chief
contaminants: sulphated ash, nitrogen, phosphorus); tglycocholic
acid, as sodium salt, Sigma Chemical Company Ltd, 99% pure.
One subject was studied during infusions ofGCDC 10 mmol/l and
GCDC 10 mmol/l + lecithin on sepairate occasions; thrcc subjects
were studied during infusion ofGCDC 15 mmol/l+ lecithin and GC
15 mmol/l+lecithin on separate occasions.
and GCDC 10 mmol/l+lecithin (L) and three with
GCDC 15 mmol/1+L and GC 15 mmol/l+L. Each
solution was infused on a separate day in randomised
order. To avoid stimulation of enslogenous bile acid
secretion by feeding, the subjects were studied in the
fasted state.
The subjects were instructed to limit their meals
from lunchtime on the day before each study to those
foodstuffs which result in little, or no rise in breath
hydrogen (rice and meat). After an overnight fast, all
subjects swallowed an assembly of polyvinyl tubes
weighted at the end with a double balloon containing
1 ml mercury. The assembly contained one radio-
opaque tube to facilitate fluoroscopic localisation.
When the assembly entered the duodenum a small
amount of air was injected into the terminal balloon
to accelerate intubation, until the infusion port,
marked by a small radio-opaque plug, was placed 10
cm beyond the duodenojejunal flexure. The balloon
was then deflated and the mercury completely
aspirated.
In the experiments testing GCDC 10 mmol/l±L
(n=10) the tube assembly consisted of two single
lumen tubes (external diameter=2 mm), one for
infusion and one for balloon inflation. In the 12
experiments testing GCDC 15 mmol/l+L and GC 15
mmol/l+L a three lumen (external diameter=2 mm)
tube (Dural Plastics, Australia) was added to mea-
sure jejunal intraluminal pressures at 5, 20, and 35 cm
beyond the infusion port. The three manometry
tubes were continuously perfused with water at 0-15
ml/min by a low compliance pneumohydraulic capil-
lary infusion system (Mui Scientific), permitting a
response time of 35 mmHg/sec. The tubes were
connected to external pressure transducers (Statham
p23ID) and signals recorded on a polygraph (Grass,
model 7). A further polygraph channel monitored
respiration through a pneumatic belt placed round
subjects' chest.
When the tube assembly was in place, a cannula
was inserted into a forearm vein using local anaes-
thetic and kept patent with heparinised saline. After
one hour's rest in the experiments testing GCDC 10
mmol/l±L, and after appearance of phase 3 of a
migrating motor complex (MMC) detected by the
three manometry ports in the experiments testing
GCDC 15 mmol/l+L and GC 15 mmol/l+L, the
study started as described in Figure 1. In one subject
who did not have phase 3 MMC after four hours of
recording on the first study day, GC and control study
were performed starting in phase 2 without waiting
for an activity front.
Solutions described above were infused at 3 ml/min
using an infusion pump (MHRE Mk4 Flow Inducer,
Watson-Marlow Ltd, England) for 80 minutes.
Simultaneously saline for the first 30 minutes, and a
solution containing lactulose 5 g for the following
50 minutes was infused at 1 ml/min. This quantity
of lactulose was approximately equivalent to
unabsorbed carbohydrate after an ordinary meal.'4
All infusates were iso-osmotic and pH was adjusted
to 7 0 using NaOH.
MEASUREMENT OF BREATH HYDROGEN
Using a modified Haldane Priestley tube, end expira-
tory breath samples were taken every five minutes
from the beginning of the infusion for 150 minutes, or
until a sustained hydrogen concentration rise was
detected in breath.
Breath hydrogen was measured using an electro-
chemical detector (GMI, Renfrew, Scotland) with a
sensitivity of 2 ppm and an accuracy of ±2%. Small
bowel transit time was defined as time elapsed when
increase of breath hydrogen of at least 3 ppm above
baseline occurred, continuing to rise for at least 30
minutes.
Jejunal
infusion [
Breath
hydrogen
Manometry (*)
Blood
samples
Bile acid or saline
3ml/min
Saline LactuloseEvy 5m/min
Every 5mmn
+ , , 4 4 4
0 30 60 90 120 150
Time (minutes)
Fig. 1 Diagram illustrating the protocol ofall experiments.
(*) in the experiments testing glycochenodeoxycholic acid 15
mmolll+ lecithin and glycocholic acid 15 mmolll+ lecithin
only (n= 12).
790
 group.bmj.com on November 13, 2012 - Published by gut.bmj.comDownloaded from 
Bile acids and small bowel motility
MEASUREMENT OF SERUM BILE ACIDS
Blood samples were taken at 0, 30, 60, 90, 120, 150
minutes for measurement of total bile acids in the
experiments using GCDC and cholylglycine in the
experiments using GC (Fig. 1). Total bile acids were
measured by direct spectrophotometry (Enzabile,
Nyegaard) using an automatic analyser (Cobas Mira,
Roche) with a good reproducibility (CV=4-1%;
n= 10). Cholylglycine was measured using a specific
radioimmunoassay (CG RIA, Abbott Diagnostics),
giving a CV of 3-8% (n= 10). For total bile acids and
cholylglycine, peak incremental response (PIR) and
integrated incremental response (IIR=area under
the curve taking the basal value as zero) were
calculated.
ANALYSIS OF PRESSURE RECORDS
After Kerlin and Phillips," phase 1 was defined as
quiescence, phase 2 as intermittent activity and phase
3 as three minutes or more of uninterrupted rhythmic
contractions, followed by quiescence. Migration
required the recording of phase 3 activity successively
from all three recording ports. Migrating motor
complexes were defined as starting at the end of
a migrated phase 3 and terminating at the end of
the next one. All pressure tracings were blindly
measured by one of the authors. Tracings were
quantitatively analysed with respect to duration of
MMC and its phases, and with respect to percentage
duration of pressure activity during phase 2. The
latter variable was calculated for each experiment as
a whole and divided into 30 min epochs. In addition
tracings were qualitatively analysed for presence of
specific patterns of contractions, defined according to
Summers et al."
Calculations of percentage duration of pressure
activity during phase 2 were carried out twice
(n=21), giving a CV of 3-5%.
STATISTICAL ANALYSIS
Results, expressed as mean (SE), were analysed
using Student's t test.
Results
SMALL BOWEL TRANSIT TIME
Solutions containing GCDC 15 mmol/l and GC 15
mmol/l significantly prolonged SBTT I158-3 (12.5) v
111.7 (17.6) and 103 3 (21.8) v 700 (14.9), p<0.021.
Solutions containing GCDC 10 mmol/l either with or
without lecithin had a less consistent effect on SBT-F
[145-0 (13.2) v 115-0 (19.5) and 90-0 (11.7) v 84-0
(8.3), p=ns] (Fig. 2).
MOTILITY
Duration of MMC and of its phases was not altered
significantly by infusions ofGCDC 15 mmol/l and GC
15 mmol/l GC (Fig. 3). Infusion with GCDC 15
mmol/l produced decreased pressure activity during
phase 2 and this reduction appeared to be more
marked than that due to GC 15 mmol/l, when
compared with saline [Fig. 4; 13-1 (1-8)% v 28-1
p=NS
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Fig. 2 Small bowel transit time of lactulose when the jejunum of healthy volunteers was infused with saline (0), GCDC
(A) or GC (-). Individual values and means (SE). GCDC=glycochenodeoxycholic acid, GC=glycocholic acid,
L=lecithin.
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Fig. 3 Duration ofmigrating motor complex (MMC) and
ofits phases when thejejunum ofhealthy volunteers was
infused with saline, GCDC 15 mmol/l+L or GC 15
mmol/l+ L. [means (SE)]. GCDC=glycochenodeoxycholic
acid, GC=glycocholicacid, L=lecithin.
(3 4)%, p<0.01 and 29-2 (5-5)% v 34*9 (3-9)%,
p<0.05 respectively]. Dividing the analysis of phase 2
pressure activity in 30 min epochs, it is apparent that
inhibition of activity by GCDC (Fig. 5) was not
immediate and persisted in all subjects after the
infusion ended (p<005). When 30 min epochs were
sampled for the GC studies, a lower mean pressure
activity of phase 2 was seen along the whole of the GC
experiment compared to saline, but the difference
failed to reach statistical significance in any of the
epochs. Qualitative analysis of pressure records
showed runs of discrete clustered contractions in
three subjects during saline infusion (occupying
7.6% to 18-5% of total duration of phase 2), in no
subject during GCDC infusion and in two subjects
during GC infusion (occupying 11-7% and 15-3% of
phase 2).
SERUM BILE ACIDS
Compared with saline, total bile acid and cholyl-
glycine IIR and PIR were significantly (p<0-05)
higher after all solutions containing bile acids (Table
2). Considering all the 22 infusions of bile acids
together, the peak serum bile acid concentration
occurred 33-7 (6.6) minutes before (p<0001) the rise
in breath hydrogen. In particular peak serum bile
acid concentration preceded the arrival of lactulose
in the caecum in 17 of the 22 infusions.
Discussion
Bile acids are generally considered to have a stimula-
tory effect on gut motility and transit. The present
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Fig. 4 Percentage duration ofpressure activity ofphase2 of
migrating motor complex when thejejunum ofhealthy
volunteers was infused with saline (a), GCDC 15 mmolll+L
(A) or GC15 mmolll+L (-). Individual values and means
(SE). GCDC=glycochenodeoxycholic acid,
GC=glycocholicacid, L=lecithin.
study suggests that the subject is probably more
complicated than previously thought. Glycocheno-
deoxycholic acid and GC, the two main forms of
primary bile acids present in human bile,'7 when
infused in the jejunum of healthy man did not
stimulate motility. On the contrary, at a concentra-
tion of 15 mmol/l (total amount of 5 mmol) they
appeared to decrease jejunal intraluminal pressures
and delay SBTT. In contrast with previous animal
studies,'5 bile acids were infused in the present study
at a physiological rate'2 '8 and concentration,'9 com-
parable with the postprandial state. The serum bile
acid curves, which were similar to those obtained
after a 440 kcal liquid meal2" support this contention.
The effect on SBTT appeared to be dependent on the
bile acid concentration and/or rate of infusion,
because GCDC 10 mmol/l did not produce significant
slowing of transit. Although it cannot be excluded
that delay in breath hydrogen rise was due to an effect
of bile acids entering the large bowel on hydrogen
production, this possibility is unlikely as we have
shown bile acids to have an inhibitory effect on small
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Fig. 5 Percentage duration ofpressure activity ofphase2 of
migrating motor complex when thejejunum ofhealthy
volunteers was infused with saline (0) or GCDC 15
mmol/l+L (A) [means (SE)]. Analysis in 30 min epochs.
GCDC=glycochenodeoxycholicacid, L=lecithin.
intestinal transit also using a dye dilution technique
(unpublished data).
The reason why bile acids slowed SBTT and
inhibited motility is unknown. A few observations,
however, shed some light on the possible mechanism.
First, in the GCDC 15 mmol/I experiments where
inhibition of motility was more marked, it was clear
(Fig. 5) that decrease in intraluminal pressure activity
was delayed with respect to the start of the GCDC
infusion. Second, unpublished work in our labora-
tory investigating the effect of ileal infusion ofGCDC
on the jejunum and the ileum, showed a pattern of
inhibition of jejunal motility similar to the one
observed in the present study and a strikingly
immediate inhibition in motility in the ileum exposed
to the infused GCDC. These observations lead us to
the hypothesis that the inhibitory responses recorded
in the present study are mediated through bile acid
Table 2 Serum bile acid concentrations during all
experiments: means (SE)
Fasting PIR IIR
(PmolIl) (pmolIl) (p.molIl-h)
GCDC 10 mmol/I 1.8(0.5) 5.2(16)* 150.6(53.7)*
saline 1.6(0.4) 0.4(0.4) -6.3 (16.8)
GCDC IO mmol/l+ L 1.6(0.2) 6.0(13)* 163.7(39-9)*
saline 2-3 (0(6) 15 (0(5) 13 0(15.0)
GCDC15mmol/l+L 2 3(0.2) 97 (4-5)* 219-6(100.6)*
saline 3.2(0.3) 0.4(0.3) -19.6(8-2)
GC 15 mmol/l+L 0-10(0.07) 44(1 5)* 104-9(29.7)*
saline 0.11(0-03) 0(2(0.1) 3-9(2-4)
*
=different from control (p<O.05). GCDC=glycochenodeoxy-
cholic acid. GC=glycocholic acid. L=lecithin.
specific chemoreceptors located in the ileum. The
inhibition of motility may favour absorption of bile
acids and minimise their escape into the large bowel.
This hypothesis is supported by the fact that peak
serum bile acid concentration occurred during most
infusions containing bile acids before lactulose
reached the caecum, suggesting that transit might
have been in some way dependent on absorption of
bile acids.
The presence of lecithin has been shown to abolish
the inhibitory effect of dihydroxy bile acids on water
and electrolyte absorption from the human jejunum,
probably by decreasing the concentration of bile
acids in monomeric form.6 In the present study most
of the experiments were done with lecithin added to
the infused bile acids, to avoid unphysiological
jejunal secretion and mimic endogenous input.
Because GCDC was infused in monomeric form only
at a concentration (10 mmol/l) ineffective on SBTT,
our experiments could not clarify whether the effect
of bile acids on small bowel motility and transit is
influenced by their physicochemical state.
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